The struggling Danish company says it looks to reorganize, with the impact on North Carolina workers still unclear.

The company downgraded its guidance for the second time in six weeks as it announced a restructuring plan.

FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it ...

The Danish pharmaceutical giant, which is looking to revive growth, used to be Europe's most valuable company listed on ...

Novo Nordisk announced plans to cut about 9,000 jobs, or 11.5% of its global workforce, according to CNBC. The Danish ...

Danish drugmaker warns over slowing growth as Ozempic and Wegovy producer faces pressure from US rival Eli Lilly ...

Novo, which has 78,400 positions globally, said about 5,000 of the job cuts will be in its native Denmark. Read more at ...

Novo Nordisk, the maker of blockbuster weight-loss drug Wegovy, said on Wednesday it will cut 9,000 jobs in a bid to reignite ...

The Danish pharma giant outlined proposals to shed around 11% of its 78,400-strong workforce amid stiff competition from ...

Novo Nordisk announced an 11% workforce reduction, cutting 9,000 jobs amid rising competition in obesity treatments. The ...

Novo Nordisk has mandated a return to office work for all staff to speed up decision-making and improve market execution, ...